Varicella‐Zoster Virus–Specific Immune Responses in Elderly Recipients of a Herpes Zoster Vaccine
Top Cited Papers
Open Access
- 15 March 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 197 (6), 825-835
- https://doi.org/10.1086/528696
Abstract
BackgroundA double-blind, placebo-controlled trial that involved 38,546 subjects ⩾60 years old demonstrated efficacy of a high-potency live-attenuateKeywords
This publication has 40 references indexed in Scilit:
- The optimization and validation of the glycoprotein ELISA assay for quantitative varicella-zoster virus (VZV) antibody detectionJournal of Medical Virology, 2006
- A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older AdultsNew England Journal of Medicine, 2005
- Case-control study of the effect of mechanical trauma on the risk of herpes zosterBMJ, 2004
- Decline in Varicella‐Zoster Virus (VZV)–Specific Cell‐Mediated Immunity with Increasing Age and Boosting with a High‐Dose VZV VaccineThe Journal of Infectious Diseases, 2003
- Development and Validation of a Gamma Interferon ELISPOT Assay for Quantitation of Cellular Immune Responses to Varicella-Zoster VirusClinical and Diagnostic Laboratory Immunology, 2001
- Herpes Zoster in Older AdultsClinical Infectious Diseases, 2001
- The incidence of herpes zosterArchives of Internal Medicine, 1995
- Clinical and Subclinical Reactivations of Varicella-Zoster Virus in Immunocompromised PatientsThe Journal of Infectious Diseases, 1986
- Population-Based Study of Herpes Zoster and Its SequelaeMedicine, 1982
- Immune responses to varicella-zoster in the agedArchives of Internal Medicine, 1982